Compugen (CGEN) EBITDA (2009 - 2026)

Compugen has disclosed EBITDA across 18 years of filings, most recently posting $9.0 million for Q1 2026.

• EBITDA for Q1 2026 came in at $9.0 million, up 7.41% year-over-year; the trailing twelve-month figure through Mar 2026 was $31.9 million (up 313.16% YoY), and the FY2025 annual result was $31.3 million, up 310.37% from the prior year.
• EBITDA came in at $9.0 million for Q1 2026 at Compugen, down from $56.0 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $56.0 million in Q4 2025 to a low of -$30.5 million in Q2 2023.
• The 5-year median for EBITDA is -$3.5 million (2022), against an average of $916058.8.
• Peak annual rise in EBITDA reached 848.94% in 2025, while the deepest fall reached 275.56% in 2025.
• Compugen's EBITDA stood at -$3.5 million in 2022, then soared by 609.61% to $18.0 million in 2023, then sank by 141.61% to -$7.5 million in 2024, then soared by 848.94% to $56.0 million in 2025, then plunged by 83.91% to $9.0 million in 2026.
• The last three EBITDA figures came in at $9.0 million (Q1 2026), $56.0 million (Q4 2025), and -$7.9 million (Q3 2025), per Business Quant data.